INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,943,599 | +8.8% | 2,294,796 | -9.1% | 0.02% | +13.6% |
| Q2 2023 | $53,269,967 | +26.3% | 2,524,643 | +2.0% | 0.02% | +22.2% |
| Q1 2023 | $42,188,315 | -18.9% | 2,474,388 | -5.0% | 0.02% | -21.7% |
| Q4 2022 | $52,031,596 | -3.7% | 2,604,184 | +3.8% | 0.02% | -11.5% |
| Q3 2022 | $54,034,000 | -2.5% | 2,508,562 | -10.7% | 0.03% | +4.0% |
| Q2 2022 | $55,418,000 | -20.0% | 2,810,224 | -4.7% | 0.02% | -7.4% |
| Q1 2022 | $69,303,000 | -9.7% | 2,949,049 | +4.6% | 0.03% | 0.0% |
| Q4 2021 | $76,790,000 | +25.8% | 2,819,013 | +27.2% | 0.03% | +12.5% |
| Q3 2021 | $61,023,000 | +4.8% | 2,215,802 | +8.3% | 0.02% | +4.3% |
| Q2 2021 | $58,239,000 | -6.1% | 2,046,355 | +12.4% | 0.02% | -14.8% |
| Q1 2021 | $61,997,000 | +1.6% | 1,820,242 | -0.7% | 0.03% | -6.9% |
| Q4 2020 | $61,017,000 | -9.7% | 1,832,886 | -12.8% | 0.03% | -19.4% |
| Q3 2020 | $67,535,000 | +44.8% | 2,101,261 | +24.1% | 0.04% | +33.3% |
| Q2 2020 | $46,626,000 | +2247.7% | 1,693,034 | +1266.5% | 0.03% | +2600.0% |
| Q1 2020 | $1,986,000 | -29.9% | 123,900 | +4.4% | 0.00% | -50.0% |
| Q4 2019 | $2,835,000 | +50.3% | 118,700 | +11.0% | 0.00% | +100.0% |
| Q3 2019 | $1,886,000 | -59.0% | 106,900 | -40.6% | 0.00% | -66.7% |
| Q2 2019 | $4,604,000 | +16.3% | 179,854 | +32.1% | 0.00% | 0.0% |
| Q1 2019 | $3,958,000 | +168.3% | 136,152 | +21.1% | 0.00% | +200.0% |
| Q4 2018 | $1,475,000 | -36.0% | 112,400 | -1.4% | 0.00% | -50.0% |
| Q3 2018 | $2,305,000 | -14.5% | 114,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,696,000 | -34.1% | 114,000 | -37.3% | 0.00% | -33.3% |
| Q1 2018 | $4,094,000 | -14.1% | 181,800 | +19.0% | 0.00% | 0.0% |
| Q4 2017 | $4,764,000 | +13.1% | 152,800 | +13.2% | 0.00% | 0.0% |
| Q3 2017 | $4,213,000 | +170.8% | 135,000 | +48.8% | 0.00% | +200.0% |
| Q2 2017 | $1,556,000 | +2.2% | 90,700 | +4.4% | 0.00% | 0.0% |
| Q1 2017 | $1,522,000 | +32.3% | 86,900 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,150,000 | -8.9% | 86,900 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,262,000 | +47.3% | 86,900 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $857,000 | -22.2% | 86,900 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,101,000 | -33.0% | 86,900 | -4.1% | 0.00% | 0.0% |
| Q4 2015 | $1,644,000 | -2.3% | 90,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,682,000 | -24.1% | 90,600 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $2,215,000 | +76.9% | 90,700 | +50.7% | 0.00% | +100.0% |
| Q1 2015 | $1,252,000 | +34.5% | 60,200 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $931,000 | +18.4% | 60,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $786,000 | -34.7% | 60,200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,203,000 | +14.7% | 60,200 | +9.2% | 0.00% | 0.0% |
| Q1 2014 | $1,049,000 | +14.1% | 55,105 | +2.0% | 0.00% | 0.0% |
| Q4 2013 | $919,000 | +9.0% | 54,005 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $843,000 | +301.4% | 54,005 | +207.1% | 0.00% | – |
| Q2 2013 | $210,000 | – | 17,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |